Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.04 USD | +0.74% | -0.83% | +16.04% |
May. 01 | LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance | MT |
May. 01 | Transcript : LivaNova PLC, Q1 2024 Earnings Call, May 01, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company is in a robust financial situation considering its net cash and margin position.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- With an expected P/E ratio at 86.69 and 34.88 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.04% | 3.25B | B- | ||
-7.38% | 177B | C+ | ||
-0.46% | 108B | C | ||
-6.98% | 65.55B | A | ||
+2.65% | 50.66B | B- | ||
+5.27% | 42.58B | B- | ||
+5.76% | 40.74B | B+ | ||
+19.92% | 31.07B | B | ||
+16.18% | 25.45B | A- | ||
-7.00% | 23.85B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LIVN Stock
- Ratings LivaNova PLC